Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Long-Term Investments (2019)

Historic Long-Term Investments for Vanda Pharmaceuticals (VNDA) over the last 2 years, with Q3 2019 value amounting to $61.8 million.

  • Vanda Pharmaceuticals' Long-Term Investments changed N/A to $61.8 million in Q3 2019 from the same period last year, while for Sep 2019 it was $61.8 million, marking a year-over-year change of. This contributed to the annual value of $19.0 million for FY2011, which is N/A changed from last year.
  • Per Vanda Pharmaceuticals' latest filing, its Long-Term Investments stood at $61.8 million for Q3 2019.
  • In the past 5 years, Vanda Pharmaceuticals' Long-Term Investments ranged from a high of $61.8 million in Q3 2019 and a low of $12.5 million during Q2 2019